Atradius and Kemiex Launch Digital Market Place

Press release

The collaboration between Atradius and Kemiex is an important milestone in the use of the latest technology in order to provide customers with innovative solutions

Atradius and Kemiex launch a digital trading platform for raw materials in the pharma, vet, food and feed industries. This new digital market place enables buyers and sellers of Active Pharmaceutical Ingredients (APIs) and additives to identify reliable trade partners and to trade safely. Atradius will offer support by providing credit risk insight and trade insurance for trade partners.

The platform has been designed as an alternative for existing trading procedures that are often time consuming, prone to errors and might be limited to personal networks. Atradius and Kemiex also anticipate on the need in the human and animal health and nutrition industries to comply with strict regulations relating to quality control. Atradius contributes to the safety and transparency of the platform by providing a trade insurance for single transactions through one click on the Kemiex platform.

Global digital marketplace

The users of the platform are instantly connected with a worldwide network of qualified parties, enabling them to shorten the procedures for transactions, to agree on competitive prices and to remain in control during the process of trading. The main benefit is that buyers and sellers can do business with reliable parties that comply with relevant regulations and quality controls and are credit worthy. Kemiex estimates whether a company on the platform complies with quality standards, whereas Atradius analyses the credit worthiness of those acting on the platform. Together, they evaluate companies, their transactions and the behaviour of traders in order to ensure that transacting on the platform is as safe as possible.

Isidoro Unda, CEO of Atradius: “This strategic partnership is an excellent proof of our capabilities to create innovative solutions for our customers and develop new business around credit insurance. It is our responsibility to be at the forefront of digitalization and help our clients succeed in their global trade”.

Pau Franquet, CEO of Kemiex: “Almost hundred early adopter companies from pharma, vet, food and feed industries are excited to use this unprecedented feedstock trading solution in their procurement or distribution units. While there are other matchmaking solutions for certain aspects of the sourcing process, we are confident to say that Kemiex is the first integrated online trading platform providing safe trading with reliable counterparties, worldwide”.

The collaboration between Atradius and Kemiex is an important milestone in the use of the latest technology in order to provide customers with innovative solutions. Kemiex makes use of the latest trends in the field of digitization, connectivity, big data and social functions in order to offer users a new experience.

 

Disclaimer

Each publication available on or from our websites, such as, but not limited to webpages, reports, articles, publications, tips and helpful content, trading briefs, infographics, videos (each a “Publication”) is provided for information purposes only and is not intended as a recommendation or advice as to particular transactions, investments or strategies in any way to any reader. Readers must make their own independent decisions, commercial or otherwise, regarding the information provided. While we have made every attempt to ensure that the information contained in any Publication has been obtained from reliable sources, Atradius is not responsible for any errors or omissions, or for the results obtained from the use of this information. All information in any Publication is provided ’as is’, with no guarantee of completeness, accuracy, timeliness or of the results obtained from its use, and without warranty of any kind, express or implied. In no event will Atradius, its related partnerships or corporations, or the partners, agents or employees thereof, be liable to you or anyone else for any decision made or action taken in reliance on the information in any Publication, or for any loss of opportunity, loss of profit, loss of production, loss of business or indirect losses, special or similar damages of any kind, even if advised of the possibility of such losses or damages.